Company Filing History:
Years Active: 2016
Title: Mairi Haddow: Innovator in Pharmaceutical Chemistry
Introduction
Mairi Haddow is a distinguished inventor based in Bristol, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. Her work has been instrumental in advancing medical treatments and improving patient outcomes.
Latest Patents
Mairi Haddow holds a patent for the crystalline form of rivaroxaban dihydrate. This patent includes a crystalline dihydrate of Rivaroxaban, processes for its preparation, and pharmaceutical compositions containing this crystalline dihydrate. Additionally, it covers a crystalline formic acid solvate of Rivaroxaban, along with processes for preparing this solvate and its use in the manufacture of the crystalline dihydrate of Rivaroxaban. This innovation is crucial for enhancing the efficacy and stability of the drug.
Career Highlights
Mairi Haddow is currently associated with Sandoz AG, a leading global healthcare company. Her role involves extensive research and development in pharmaceutical formulations, where she applies her expertise to create effective and safe medications. Her contributions have been recognized within the industry, showcasing her commitment to advancing pharmaceutical science.
Collaborations
Mairi has collaborated with notable colleagues such as Johannes Ludescher and Hubert Sturm. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their research and development efforts.
Conclusion
Mairi Haddow is a prominent figure in the field of pharmaceutical chemistry, with a focus on innovative drug formulations. Her patent for the crystalline form of rivaroxaban dihydrate exemplifies her dedication to improving medical treatments. Through her work at Sandoz AG and collaborations with esteemed colleagues, she continues to make significant strides in the pharmaceutical industry.